Huh? The consensus estimate is 4 cents for the quarter and 18 cents for 2017. But its more about the revenues. consensus revenues expected at 85.1 Million If there is a significant beat there the stock will be up, particularly if the expected cabo revenues beat. If not the stock will be down. Either way I would not be concerned because its more about the approval for first line and the results for HCC upcoming.
Healthy pull back because all the cancer drug companies are beating estimates and seeing Increase sales. EXEL will beat and show higher sales. Strong buy!
4 days left to buy cheap!! 😂
A quick look at the IBB chart says it all.
EXEL. LIKE A ROCK AFTER BIG NAS SELL OFF
Hairy G. Balls
Told ya an offer of $40's coming but it will be rejected! 70's bro, 70's this FALL!
It's never too late to buy EXEL!!!
Sell off into earnings....Typical.
I just added more to my portfolio, all I hear is good news for this stock.
Have been trading this stock since early 2015 at $1.62. What a great company! I've found a goldmine!
EXEL Got upgrade from BAC TODAY
All of a sudden.Every stocks down why?
Hit it's new 52 week high AND...new Ppp
Poor Anonymous, needs some attention.
BIogen just reported massive beat, rising tide lifts all boats!
Hit new high today. Nice strong day. Lets go $30 !!!
Folks what are your predictions on earnings? I believe It will be a solid beat!!
Hairy G. Balls
Need me to kaboom it to $29 this week? Say it! kaboom!!!!!!!!!!!!!!!!!!!!!!!